What is pityriasis alba?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pityriasis Alba?

Pityriasis alba is a common, benign hypopigmentation disorder primarily affecting children and adolescents, characterized by superficial, hypopigmented macules or patches with fine scale, most commonly appearing on the face and upper extremities. 1

Clinical Characteristics

  • Typical presentation: Round to oval hypopigmented patches, usually a few centimeters in diameter, with fine scale and ill-defined borders 1, 2
  • Distribution: Most frequently affects the face, upper arms, neck, and trunk 1, 3
  • Age group: Predominantly occurs in children and preadolescents, with equal incidence in boys and girls 3
  • Skin type predilection: While it occurs in all skin phototypes, it is markedly more visible and commonly diagnosed in individuals with darker skin (phototypes III-VI) due to greater contrast with surrounding normal skin 1, 2
  • Associated symptoms: Mild pruritus may be present, though many cases are asymptomatic 1, 2

Pathophysiology and Associated Conditions

  • Strong association with atopic dermatitis: Pityriasis alba is considered by many experts to be a minor manifestation or milder form of atopic dermatitis 4, 1, 2
  • Recognized as an associated feature: The American Academy of Dermatology lists pityriasis alba among the clinical associations that help suggest the diagnosis of atopic dermatitis, though it is too non-specific to be used as a defining criterion 4
  • Histologic findings: Biopsy specimens consistently show spongiosis, follicular spongiosis, focal parakeratosis, acanthosis in the epidermis, and superficial perivascular lymphocytic infiltrate 3
  • Mechanism: Poor cutaneous hydration and inappropriate melanin transfer appear central to pathogenesis, resulting in the characteristic hypopigmentation 2

Clinical Course and Triggers

  • Natural history: Extended, multistage course with spontaneous remissions and recurrences over months to years 1
  • Initial phase: Lesions may be preceded by subtle erythematous changes before hypopigmentation develops 1
  • Exacerbating factors: Sun exposure increases the contrast between normal and affected skin, making lesions more cosmetically apparent and prompting patients to seek care 2
  • Other potential triggers: Beauty treatments, xerosis, and possibly microorganisms have been reported, though etiology remains incompletely understood 1, 2

Differential Diagnosis

Critical distinctions to make:

  • Pityriasis versicolor alba: Distinguished by positive KOH preparation showing hyphae and spores; Wood's lamp examination shows yellow-green fluorescence 5, 2
  • Vitiligo: Shows complete depigmentation (chalk-white) rather than hypopigmentation, with sharply demarcated borders and no scale 2
  • Nevus depigmentosus: Present from birth or early infancy, remains stable in size and distribution 2
  • Nevus anemicus: Blanches with diascopy due to vascular abnormality rather than pigmentary change 2

Management Approach

First-line conservative management:

  • Patient education: Counsel on proper skin care, adequate hydration, and use of emollients to address xerosis 2
  • Photoprotection: Recommend broad-spectrum sunscreen (SPF 20 or higher) to minimize contrast between affected and normal skin 6
  • Moisturizers: Regular application of emollients addresses the underlying poor cutaneous hydration 2, 6

Pharmacologic treatment when intervention is desired:

  • Topical calcineurin inhibitors: Tacrolimus ointment 0.1% applied twice daily demonstrates statistically significant improvement in hypopigmentation, with complete resolution by 9 weeks in clinical trials 6
  • Efficacy data: Tacrolimus reduced hypopigmentation scores from baseline 2.38 to 0.00 at week 9, significantly superior to moisturizers alone (P<0.001) 6
  • Safety profile: Mild transient burning reported in 11.5% of patients; otherwise well-tolerated 6
  • Topical corticosteroids: Low-potency corticosteroids may be used when inflammation is present, though evidence is limited 2

Important clinical caveats:

  • The disorder is primarily of cosmetic significance with no systemic implications 7
  • Many patients do not seek treatment due to the benign nature of the condition 7
  • Spontaneous resolution typically occurs over time without intervention 1, 7
  • Screen for and address underlying atopic dermatitis when present, as this may improve pityriasis alba 4, 1

References

Research

Clinicopathologic study on pityriasis alba.

Boletin de la Asociacion Medica de Puerto Rico, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis of Pityriasis Rubra Pilaris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.